Published January 21, 2026
| Version v1
Other
Open
What is the efficacy of tumor markers in screening for occult malignancies in patients with thromboembolic disease?
Description
The efficacy of tumor marker screening for occult malignancies in patients with thromboembolic disease is generally limited. Extensive screening has not shown additional benefits over limited or standard screening methods concerning mortality and clinical outcomes.
Files
887ebe04-0af3-4c72-93e0-7079126fcdef.pdf
Files
(18.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ad6b9cd8e525a1a07e3ac2d04a17fca5
|
18.6 kB | Preview Download |